ISSN: 1859 - 2872
Evaluation of outcome for percutaneous translumina angioplasty treatment of chronic illac artery diseases
Main Article Content
Keywords
Abstract
Objective: To determine the efficacy, results of percutaneous transluminal angioplasty (PTA) in patients with chronic iliac diseases. Subject and method: 75 patients (96 lessons), who indicated iliac artery percutaneous angioplasty. Methods: A descriptive and cross-sectional study from September 2016 to December, 2020 at Bach Mai Hospital, follow-up 12 months. Result: Technicial successsful rate was 96%; Clinical success rate was 83.3%, dynamical success rate was 76.0%, average ABI: Pre-procedure: 0.43 ± 0.33, post procedure: 0.62 ± 0.25, 1 month: 0.82 ± 0.18, 3 months: 0.89 ± 0.15, 6 months: 0.91 ± 0.14, 12 months 0.89 ± 0.17. The complication included: Access site hematoma (6.7%), acute renal failure (4.0%), dissection (1.3%), acute thrombosis (2.7%). Conclusion: PTA in patients with chronic iliac diseases is a feasible and effective procedure.
Article Details
References
2. Trần Đức Hùng (2016) Nghiên cứu đặc điểm lâm sàng, cận lâm sàng và kết quả điều trị can thiệp nội mạch ở bệnh động mạch chi dưới mạn tính. Học viện Quân Y, Hà Nội.
3. Vũ Điện Biên (2006) Giáo trình nội tim mạch. Viện Nghiên cứu Y Dược học lâm sàng 108, Tập 2, tr. 16-41.
4. Christopher DL (2006) Endovascular management of iliac artery occlusions: Extending treatment to TransAtlantic Inter-Society Consensus class C and D patients. J Vasc Surg 4(3): 2-9.
5. Hausegger (2010) Iliac artery stenting - clinical experience with the palmaz stent, wallstent, and strecker stent. Acta Radiologica 33(4): 292-296.
6. John HR (2017) Results from the VISIBILITY Iliac study: Primary and cohort outcomes at 9 months. Journal of Endovascular Therapy 24(3): 432-348.
7. Johnana LB (1997) Meta-analysis of the results of percutaneous transluminal angioplasty and stent placement for aortoiliac occlussive disease. Radiology 204: 87-96.
8. Stoner MC (2016) Reporting standards of the Society for Vascular Surgery for endovascular treatment of chronic lower extremity peripheral artery disease. J Vasc Endovasc Surg 64(1): 1-21.
9. Ichihashi S, Higashiura W, Itoh H, Sakaguchi S, Nishimine K, Kichikawa K (2011) Long-term outcomes for systematic primary stent placement in complex iliac artery occlusive disease classified according to Trans-Atlantic Inter-Society Consensus (TASC)-II. J Vasc Surg 53(4): 992-999. doi: 10.1016/j.jvs.2010.10.069.
10. Lee SR, Zhuo H, Zhang Y, Dahl N, Dardik A, Ochoa Chaar CI (2020) Risk factors and safe contrast volume thresholds for postcontrast acute kidney injury after peripheral vascular interventions. J Vasc Surg 72(2): 603-610.e1. doi: 10.1016/j.jvs.2019.09.059.
11. Tamer EA et al (2020) Role of endovascular Intervention in Iliac artery disease TASC C and D classification. Med. J. Cairo Univ 88(2): 541-548.
12. Ozkan U, Oguzkurt L, Tercan F (2010) Technique, complication, and long-term outcome for endovascular treatment of iliac artery occlusion. Cardiovasc Intervent Radiol 33(1): 18-24. doi: 10.1007/s00270-009-9691-7.
13. Aboyans V, Ricco JB, Bartelink MEL, Björck M, Brodmann M, Cohnert T, Collet JP, Czerny M, De Carlo M, Debus S, Espinola-Klein C, Kahan T, Kownator S, Mazzolai L, Naylor AR, Roffi M, Röther J, Sprynger M, Tendera M, Tepe G, Venermo M, Vlachopoulos C, Desormais I; ESC Scientific Document Group (2018) 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery. Eur Heart J 39(9):763-816. doi: 10.1093/eurheartj/ehx095.
Article Sidebar
